Bioorganic chemistry · 2024
Rational design of 2-benzylsulfinyl-benzoxazoles as potent and selective indoleamine 2,3-dioxygenase 1 inhibitors to combat inflammation.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wang Ting, Liao Xiufeng, Zhao Xiaodi, Chen Kai, Chen Yangzhonghui, Wen Hui, Yin Dali, Wang Yuchen, Lin Bin, Zhang Sen, Cui Huaqing
Аннотация
Mimicking the transition state of tryptophan (Trp) and O2 in the enzymatic reaction is an effective approach to design indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors. In this study, we firstly assembled a small library of 2-substituted benzo-fused five membered heterocycles and found 2-sulfinyl-benzoxazoles with interesting IDO1 inhibitory activities. Next the inhibitory activity toward IDO1 was gradually improved. Several benzoxazoles showed potent IDO1 inhibitory activity with IC50 of 82-91 nM, and exhibited selectivity between IDO1 and tryptophan 2,3-dioxygenase (TDO2). Enzyme binding studies showed that benzoxazoles are reversible type II IDO1 inhibitors, and modeling studies suggested that the oxygen atom of the sulfoxide in benzoxazoles interacts with the iron atom of the heme group, which mimics the transition state of Fe-O-O-Trp complex. Especially, 10b can effectively inhibit the NO production in lipopolysaccharides (LPS) stimulated RAW264.7 cells, and it also shows good anti-inflammation effect on mice acute inflammation model of croton oil induced ear edema.
Предметные рубрики MeSH
AnimalsMiceIndoleamine-Pyrrole 2,3,-DioxygenaseDrug DesignRAW 264.7 CellsEnzyme InhibitorsStructure-Activity RelationshipLipopolysaccharidesBenzoxazolesMolecular StructureEdemaAnti-Inflammatory Agents, Non-SteroidalDose-Response Relationship, DrugInflammationHumansAnti-Inflammatory AgentsNitric OxideMale